Sustainability & Climate

South Korea's Hanwha Ocean partners with Ontario Shipyards and Mohawk College to rebuild a vital industry, create skilled jobs, and bid for Canada's future subs.

A new study reveals a breakthrough hair loss system offers clinically meaningful regrowth for menopausal women in just four months, challenging existing treatments.

Pharma giant AbbVie raises its dividend, backed by robust financials and a powerful drug pipeline that signals a thriving post-Humira growth era.

A new partnership brings continuous health monitoring to premium care, signaling a major shift toward data-driven, value-based personalized medicine.

A novel protein from water lentils just got FDA approval. With superior taste and function, Rubi Protein is set to revolutionize plant-based foods.

Maris-Tech lands a key deal for its AI tech in loitering munitions, fueling a booming market and intensifying the debate on autonomous warfare's future.

ESOA raises $20M in a public offering, eyeing acquisitions amid soaring demand for energy infrastructure driven by AI, LNG exports, and grid modernization.

WellAve Dermatology opens a Mohs surgery center in Easton, bringing a top-tier surgeon and gold-standard cancer care to a medically underserved region.

EpicQuest Education partners with a little-known firm to recruit globally for its online degrees, a high-stakes play to boost revenue and tap new markets.

Innoviva prepares for a key investor conference, spotlighting its shift to specialty drugs and navigating questions on its diversified growth strategy.

TUDOR answers enthusiast calls with a new 36mm Ranger and a striking 'Dune white' dial, blending vintage appeal with modern technical prowess.

Junior explorer One Bullion heads to PDAC 2026 to showcase its vast Botswana gold projects while shoring up market liquidity with a new agreement.

After a volatile market debut, the supersonic flight company hits the NYSE, signaling a new era for high-speed testing and air-launch services.

Benefits giant Alight faces a massive $3.1B annual loss from a goodwill writedown, suspending its dividend to focus on debt reduction and AI innovation.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

Supremex reports strong Q4 growth driven by its packaging division, erasing nearly all debt and positioning itself for an aggressive future beyond envelopes.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

With a new $50M facility from CIBC, Montreal-based AlayaCare is poised to accelerate its M&A strategy and advance its mission to digitize home care.